160 related articles for article (PubMed ID: 9237205)
1. Mapping protein-protein contact sites using cellulose-bound peptide scans.
Reineke U; Sabat R; Kramer A; Stigler RD; Seifert M; Michel T; Volk HD; Schneider-Mergener J
Mol Divers; 1996 May; 1(3):141-8. PubMed ID: 9237205
[TBL] [Abstract][Full Text] [Related]
2. Mapping of the interleukin-10/interleukin-10 receptor combining site.
Reineke U; Sabat R; Volk HD; Schneider-Mergener J
Protein Sci; 1998 Apr; 7(4):951-60. PubMed ID: 9568901
[TBL] [Abstract][Full Text] [Related]
3. Characterization of ligand binding by the human p55 tumour-necrosis-factor receptor. Involvement of individual cysteine-rich repeats.
Corcoran AE; Barrett K; Turner M; Brown A; Kissonerghis AM; Gadnell M; Gray PW; Chernajovsky Y; Feldmann M
Eur J Biochem; 1994 Aug; 223(3):831-40. PubMed ID: 8055960
[TBL] [Abstract][Full Text] [Related]
4. Evidence for conformationally different states of interleukin-10: binding of a neutralizing antibody enhances accessibility of a hidden epitope.
Reineke U; Schneider-Mergener J; Glaser RW; Stigler RD; Seifert M; Volk HD; Sabat R
J Mol Recognit; 1999; 12(4):242-8. PubMed ID: 10440995
[TBL] [Abstract][Full Text] [Related]
5. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.
Browning JL; Dougas I; Ngam-ek A; Bourdon PR; Ehrenfels BN; Miatkowski K; Zafari M; Yampaglia AM; Lawton P; Meier W
J Immunol; 1995 Jan; 154(1):33-46. PubMed ID: 7995952
[TBL] [Abstract][Full Text] [Related]
6. IL-2-induced tumor necrosis factor (TNF)-beta expression: further analysis in the IL-2 knockout model, and comparison with TNF-alpha, lymphotoxin-beta, TNFR1 and TNFR2 modulation.
Reddy J; Chastagner P; Fiette L; Liu X; Thèze J
Int Immunol; 2001 Feb; 13(2):135-47. PubMed ID: 11157847
[TBL] [Abstract][Full Text] [Related]
7. A synthetic mimic of a discontinuous binding site on interleukin-10.
Reineke U; Sabat R; Misselwitz R; Welfle H; Volk HD; Schneider-Mergener J
Nat Biotechnol; 1999 Mar; 17(3):271-5. PubMed ID: 10096295
[TBL] [Abstract][Full Text] [Related]
8. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
[TBL] [Abstract][Full Text] [Related]
9. A lymphotoxin-beta-specific receptor.
Crowe PD; VanArsdale TL; Walter BN; Ware CF; Hession C; Ehrenfels B; Browning JL; Din WS; Goodwin RG; Smith CA
Science; 1994 Apr; 264(5159):707-10. PubMed ID: 8171323
[TBL] [Abstract][Full Text] [Related]
10. Model complexes of tumor necrosis factor-alpha with receptors R1 and R2.
Fu ZQ; Harrison RW; Reed C; Wu J; Xue YN; Chen MJ; Weber IT
Protein Eng; 1995 Dec; 8(12):1233-41. PubMed ID: 8869635
[TBL] [Abstract][Full Text] [Related]
11. Epitope mapping of monoclonal antibodies to tumor necrosis factor-alpha by synthetic peptide approach.
Nagahira K; Fukuda Y; Terakawa M; Hashino J; Nasu T; Nakazato H; Nakanishi T
Immunol Lett; 1995 May; 46(1-2):135-41. PubMed ID: 7590909
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of TNF.
Jones EY; Stuart DI; Walker NP
Immunol Ser; 1992; 56():93-127. PubMed ID: 1550878
[No Abstract] [Full Text] [Related]
13. The three HveA receptor ligands, gD, LT-alpha and LIGHT bind to distinct sites on HveA.
Sarrias MR; Whitbeck JC; Rooney I; Ware CF; Eisenberg RJ; Cohen GH; Lambris JD
Mol Immunol; 2000 Aug; 37(11):665-73. PubMed ID: 11164894
[TBL] [Abstract][Full Text] [Related]
14. Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor I.
Hildt E; Oess S
J Exp Med; 1999 Jun; 189(11):1707-14. PubMed ID: 10359574
[TBL] [Abstract][Full Text] [Related]
15. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
[TBL] [Abstract][Full Text] [Related]
17. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.
Browning JL; Sizing ID; Lawton P; Bourdon PR; Rennert PD; Majeau GR; Ambrose CM; Hession C; Miatkowski K; Griffiths DA; Ngam-ek A; Meier W; Benjamin CD; Hochman PS
J Immunol; 1997 Oct; 159(7):3288-98. PubMed ID: 9317127
[TBL] [Abstract][Full Text] [Related]
18. Structural analysis of the rabbit TNF locus, containing the genes encoding TNF-beta (lymphotoxin) and TNF-alpha (tumor necrosis factor).
Shakhov AN; Kuprash DV; Azizov MM; Jongeneel CV; Nedospasov SA
Gene; 1990 Nov; 95(2):215-21. PubMed ID: 2249779
[TBL] [Abstract][Full Text] [Related]
19. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface.
Browning JL; Ngam-ek A; Lawton P; DeMarinis J; Tizard R; Chow EP; Hession C; O'Brine-Greco B; Foley SF; Ware CF
Cell; 1993 Mar; 72(6):847-56. PubMed ID: 7916655
[TBL] [Abstract][Full Text] [Related]
20. Woodchuck lymphotoxin-alpha, -beta and tumor necrosis factor genes: structure, characterization and biological activity.
Li DH; Havell EA; Brown CL; Cullen JM
Gene; 2000 Jan; 242(1-2):295-305. PubMed ID: 10721723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
